{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:40:01Z","timestamp":1794544801443,"version":"4.9.1"},"reference-count":33,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Blood microparticles (MPs) in sickle cell disease (SCD) are reportedly derived only from erythrocytes and platelets. Yet in SCD, endothelial cells and monocytes are activated and abnormally express tissue factor (TF). Thus, sickle blood might contain TF-positive MPs derived from these cells. With the use of flow cytometry to enumerate and characterize MPs, we found total MPs to be elevated in crisis (P = .0001) and steady state (P = .02) in subjects with sickle cell disease versus control subjects. These MPs were derived from erythrocytes, platelets, monocytes, and endothelial cells. Erythrocyte-derived MPs were elevated in sickle crisis (P = .0001) and steady state (P = .02) versus control subjects, as were monocyte-derived MPs (P = .0004 and P = .009, respectively). Endothelial and platelet-derived MPs were elevated in sickle crisis versus control subjects. Total TF-positive MPs were elevated in sickle crisis versus steady state (P = .004) and control subjects (P &amp;lt; .0001) and were derived from both monocytes and endothelial cells. Sickle MPs shortened plasma-clotting time compared with control MPs, and a TF antibody partially inhibited this procoagulant activity. Markers of coagulation were elevated in patients with sickle cell disease versus control subjects and correlated with total MPs and TF-positive MPs (P &amp;lt; .01 for both). These data support the concept that SCD is an inflammatory state with monocyte and endothelial activation and abnormal TF activity. (Blood. 2003;102:2678-2683)<\/jats:p>","DOI":"10.1182\/blood-2003-03-0693","type":"journal-article","created":{"date-parts":[[2003,6,17]],"date-time":"2003-06-17T00:34:45Z","timestamp":1055810085000},"page":"2678-2683","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":471,"title":["Sickle blood contains tissue factor\u2013positive microparticles derived from endothelial cells and monocytes"],"prefix":"10.1182","volume":"102","author":[{"given":"Arun S.","family":"Shet","sequence":"first","affiliation":[{"name":"From the Vascular Biology Center and Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis; and the Section of Hematology and Oncology, Hennepin County Medical Center, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Aras","sequence":"additional","affiliation":[{"name":"From the Vascular Biology Center and Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis; and the Section of Hematology and Oncology, Hennepin County Medical Center, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpna","family":"Gupta","sequence":"additional","affiliation":[{"name":"From the Vascular Biology Center and Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis; and the Section of Hematology and Oncology, Hennepin County Medical Center, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew J.","family":"Hass","sequence":"additional","affiliation":[{"name":"From the Vascular Biology Center and Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis; and the Section of Hematology and Oncology, Hennepin County Medical Center, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Rausch","sequence":"additional","affiliation":[{"name":"From the Vascular Biology Center and Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis; and the Section of Hematology and Oncology, Hennepin County Medical Center, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Saba","sequence":"additional","affiliation":[{"name":"From the Vascular Biology Center and Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis; and the Section of Hematology and Oncology, Hennepin County Medical Center, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louann","family":"Koopmeiners","sequence":"additional","affiliation":[{"name":"From the Vascular Biology Center and Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis; and the Section of Hematology and Oncology, Hennepin County Medical Center, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel S.","family":"Key","sequence":"additional","affiliation":[{"name":"From the Vascular Biology Center and Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis; and the Section of Hematology and Oncology, Hennepin County Medical Center, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Hebbel","sequence":"additional","affiliation":[{"name":"From the Vascular Biology Center and Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Minneapolis; and the Section of Hematology and Oncology, Hennepin County Medical Center, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021221553426400_REF1","doi-asserted-by":"crossref","unstructured":"Combes V, Simon AC, Grau GE, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest. 1999;104: 93-102.","DOI":"10.1172\/JCI4985"},{"key":"2020021221553426400_REF2","doi-asserted-by":"crossref","unstructured":"Aupeix K, Hugel B, Martin T, et al. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest. 1997;99: 1546-1554.","DOI":"10.1172\/JCI119317"},{"key":"2020021221553426400_REF3","doi-asserted-by":"crossref","unstructured":"Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997;89: 1121-1132.","DOI":"10.1182\/blood.V89.4.1121"},{"key":"2020021221553426400_REF4","doi-asserted-by":"crossref","unstructured":"Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood. 2000;95: 930-935.","DOI":"10.1182\/blood.V95.3.930.003k46_930_935"},{"key":"2020021221553426400_REF5","doi-asserted-by":"crossref","unstructured":"Wun T, Paglieroni T, Rangaswami A, et al. Platelet activation in patients with sickle cell disease. Br J Haematol. 1998;100: 741-749.","DOI":"10.1046\/j.1365-2141.1998.00627.x"},{"key":"2020021221553426400_REF6","doi-asserted-by":"crossref","unstructured":"Allan D, Limbrick AR, Thomas P, Westerman MP. Release of spectrin-free spicules on reoxygenation of sickled erythrocytes. Nature. 1982;295: 612-613.","DOI":"10.1038\/295612a0"},{"key":"2020021221553426400_REF7","doi-asserted-by":"crossref","unstructured":"Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med. 1997;337: 1584-1590.","DOI":"10.1056\/NEJM199711273372203"},{"key":"2020021221553426400_REF8","doi-asserted-by":"crossref","unstructured":"Solovey A, Gui L, Key NS, Hebbel RP. Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest. 1998;101: 1899-1904.","DOI":"10.1172\/JCI1932"},{"key":"2020021221553426400_REF9","doi-asserted-by":"crossref","unstructured":"Belcher JD, Marker PH, Weber JP, Hebbel RP, Vercellotti GM. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood. 2000;96: 2451-2459.","DOI":"10.1182\/blood.V96.7.2451"},{"key":"2020021221553426400_REF10","unstructured":"Embury SH, Hebbel RP, Mohandas N, Steinberg MH. Pathogenesis of vasooclusion. In: Embury SH HRP, Steinberg MH, Mohandas N, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York: Raven Press; 1994: 311-326."},{"key":"2020021221553426400_REF11","unstructured":"Francis RB Jr, Hebbel RP. Haemostasis. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Practice. New York: Raven Press; 1994: 299-310."},{"key":"2020021221553426400_REF12","doi-asserted-by":"crossref","unstructured":"Berney SI, Ridler CD, Stephens AD, Thomas AE, Kovacs IB. Enhanced platelet reactivity and hypercoagulability in the steady state of sickle cell anemia. Am J Hematol. 1992;40: 290-294.","DOI":"10.1002\/ajh.2830400409"},{"key":"2020021221553426400_REF13","doi-asserted-by":"crossref","unstructured":"Hagger D, Wolff S, Owen J, Samson D. Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls. Blood Coagul Fibrinolysis. 1995;6: 93-99.","DOI":"10.1097\/00001721-199504000-00001"},{"key":"2020021221553426400_REF14","doi-asserted-by":"crossref","unstructured":"Kurantsin-Mills J, Ofosu FA, Safa TK, Siegel RS, Lessin LS. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients. Br J Haematol. 1992;81: 539-544.","DOI":"10.1111\/j.1365-2141.1992.tb02989.x"},{"key":"2020021221553426400_REF15","unstructured":"Peters M, Plaat BE, ten Cate H, Wolters HJ, Weening RS, Brandjes DP. Enhanced thrombin generation in children with sickle cell disease. Thromb Haemost. 1994;71: 169-172."},{"key":"2020021221553426400_REF16","doi-asserted-by":"crossref","unstructured":"Tomer A, Harker LA, Kasey S, Eckman JR. Thrombogenesis in sickle cell disease. J Lab Clin Med. 2001;137: 398-407.","DOI":"10.1067\/mlc.2001.115450"},{"key":"2020021221553426400_REF17","doi-asserted-by":"crossref","unstructured":"Prengler M, Pavlakis SG, Prohovnik I, Adams RJ. Sickle cell disease: the neurological complications. Ann Neurol. 2002;51: 543-552.","DOI":"10.1002\/ana.10192"},{"key":"2020021221553426400_REF18","doi-asserted-by":"crossref","unstructured":"Key NS, Slungaard A, Dandelet L, et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood. 1998;91: 4216-4223.","DOI":"10.1182\/blood.V91.11.4216"},{"key":"2020021221553426400_REF19","doi-asserted-by":"crossref","unstructured":"Giesen PL, Rauch U, Bohrmann B, et al. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A. 1999;96: 2311-2315.","DOI":"10.1073\/pnas.96.5.2311"},{"key":"2020021221553426400_REF20","doi-asserted-by":"crossref","unstructured":"George JN, Thoi LL, McManus LM, Reimann TA. Isolation of human platelet membrane microparticles from plasma and serum. Blood. 1982;60: 834-840.","DOI":"10.1182\/blood.V60.4.834.834"},{"key":"2020021221553426400_REF21","doi-asserted-by":"crossref","unstructured":"Jimenez JJ, Jy W, Mauro LM, Horstman LL, Ahn YS. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol. 2001;112: 81-90.","DOI":"10.1046\/j.1365-2141.2001.02516.x"},{"key":"2020021221553426400_REF22","doi-asserted-by":"crossref","unstructured":"Allan D, Limbrick AR, Thomas P, Westerman MP. Microvesicles from sickle erythrocytes and their relation to irreversible sickling. Br J Haematol. 1981;47: 383-390.","DOI":"10.1111\/j.1365-2141.1981.tb02805.x"},{"key":"2020021221553426400_REF23","doi-asserted-by":"crossref","unstructured":"Naumann HN, Diggs LW, Barreras L, Williams BJ. Plasma hemoglobin and hemoglobin fractions in sickle cell crisis. Am J Clin Pathol. 1971;56: 137-147.","DOI":"10.1093\/ajcp\/56.2.137"},{"key":"2020021221553426400_REF24","doi-asserted-by":"crossref","unstructured":"Reiter CD, Wang X, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8: 1383-1389.","DOI":"10.1038\/nm1202-799"},{"key":"2020021221553426400_REF25","doi-asserted-by":"crossref","unstructured":"Satta N, Toti F, Feugeas O, et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol. 1994;153: 3245-3255.","DOI":"10.4049\/jimmunol.153.7.3245"},{"key":"2020021221553426400_REF26","doi-asserted-by":"crossref","unstructured":"Hebbel RP, Vercellotti GM. The endothelial biology of sickle cell disease. J Lab Clin Med. 1997;129: 288-293.","DOI":"10.1016\/S0022-2143(97)90176-1"},{"key":"2020021221553426400_REF27","unstructured":"Nemerson Y. The tissue factor pathway of blood coagulation. Semin Hematol. 1992;29: 170-176."},{"key":"2020021221553426400_REF28","doi-asserted-by":"crossref","unstructured":"Giesen PL, Nemerson Y. Tissue factor on the loose. Semin Thromb Hemost. 2000;26: 379-384.","DOI":"10.1055\/s-2000-8456"},{"key":"2020021221553426400_REF29","doi-asserted-by":"crossref","unstructured":"Semeraro N, Colucci M. Tissue factor in health and disease. Thromb Haemost. 1997;78: 759-764.","DOI":"10.1055\/s-0038-1657625"},{"key":"2020021221553426400_REF30","doi-asserted-by":"crossref","unstructured":"Adedeji MO, Cespedes J, Allen K, Subramony C, Hughson MD. Pulmonary thrombotic arteriopathy in patients with sickle cell disease. Arch Pathol Lab Med. 2001;125: 1436-1441.","DOI":"10.5858\/2001-125-1436-PTAIPW"},{"key":"2020021221553426400_REF31","doi-asserted-by":"crossref","unstructured":"Setty BN, Rao AK, Stuart MJ. Thrombophilia in sickle cell disease: the red cell connection. Blood. 2001;98: 3228-3233.","DOI":"10.1182\/blood.V98.12.3228"},{"key":"2020021221553426400_REF32","doi-asserted-by":"crossref","unstructured":"Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JW, Radder JK. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation. 2002;106: 2442-2447.","DOI":"10.1161\/01.CIR.0000036596.59665.C6"},{"key":"2020021221553426400_REF33","doi-asserted-by":"crossref","unstructured":"Gilbert GE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ. Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem. 1991;266: 17261-17268.","DOI":"10.1016\/S0021-9258(19)47368-7"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/7\/2678\/1691568\/h81903002678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/7\/2678\/1691568\/h81903002678.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T12:04:59Z","timestamp":1682510699000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/102\/7\/2678\/17981\/Sickle-blood-contains-tissue-factorpositive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,1]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,10,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-03-0693","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,1]]}}}